| Intensity-modulated radiation therapy for head and neck carcinoma V Gregoire, W De Neve, A Eisbruch, N Lee, D Van den Weyngaert, ... The Oncologist 12 (5), 555-564, 2007 | 180 | 2007 |
| Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy F Hoefkens, C Dehandschutter, J Somville, P Meijnders, D Van Gestel Radiation Oncology 11, 1-12, 2016 | 116 | 2016 |
| Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study A Holt, D Van Gestel, MP Arends, EW Korevaar, D Schuring, ... Radiation oncology 8, 1-11, 2013 | 108 | 2013 |
| Low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer P Szturz, K Wouters, N Kiyota, M Tahara, K Prabhash, V Noronha, ... Frontiers in oncology 9, 86, 2019 | 93 | 2019 |
| RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison D Van Gestel, C van Vliet-Vroegindeweij, F Van den Heuvel, W Crijns, ... Radiation Oncology 8, 1-12, 2013 | 93 | 2013 |
| DNA methylation-based biomarkers in serum of patients with breast cancer L Van De Voorde, R Speeckaert, D Van Gestel, M Bracke, W De Neve, ... Mutation Research/Reviews in Mutation Research 751 (2), 304-325, 2012 | 85 | 2012 |
| Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go? P De Bruyn, D Van Gestel, P Ost, V Kruse, L Brochez, H Van Vlierberghe, ... Current opinion in oncology 31 (2), 54-64, 2019 | 81 | 2019 |
| Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical … S Nuyts, M Lambrecht, F Duprez, JF Daisne, D Van Gestel, ... Radiotherapy and Oncology 109 (2), 323-329, 2013 | 77 | 2013 |
| Humanized mice as a valuable pre-clinical model for cancer immunotherapy research MM Cogels, R Rouas, GE Ghanem, P Martinive, A Awada, D Van Gestel, ... Frontiers in oncology 11, 784947, 2021 | 45 | 2021 |
| Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience D Van Gestel, D Van Den Weyngaert, D Schrijvers, J Weyler, ... The British journal of radiology 84 (1000), 367-374, 2011 | 40 | 2011 |
| Restoring p53 function in head and neck squamous cell carcinoma to improve treatments T De Bakker, F Journe, G Descamps, S Saussez, T Dragan, G Ghanem, ... Frontiers in oncology 11, 799993, 2022 | 37 | 2022 |
| A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer I Chitapanarux, K Chomprasert, W Nobnaop, S Wanwilairat, ... Journal of radiation research 56 (3), 529-538, 2015 | 36 | 2015 |
| The potential of helical tomotherapy in the treatment of head and neck cancer D Van Gestel, D Verellen, L Van De Voorde, B Ost, G De Kerf, ... The Oncologist 18 (6), 697-706, 2013 | 35 | 2013 |
| 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy C Artigas, P Flamen, F Charlier, H Levillain, Z Wimana, R Diamand, ... World journal of urology 37, 1535-1542, 2019 | 29 | 2019 |
| Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard? C Bouchart, J Navez, J Closset, A Hendlisz, D Van Gestel, L Moretti, ... Therapeutic advances in medical oncology 12, 1758835920936093, 2020 | 27 | 2020 |
| Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer MT Genot-Klastersky, M Paesmans, L Ameye, A Kayumba, S Beauvois, ... Supportive Care in Cancer 28, 3015-3022, 2020 | 26 | 2020 |
| Follow-up of head and neck cancer survivors: tipping the balance of intensity P Szturz, C Van Laer, C Simon, D Van Gestel, J Bourhis, JB Vermorken Frontiers in oncology 10, 688, 2020 | 25 | 2020 |
| Gemcitabine-based chemoradiation in the treatment of locally advanced head and neck cancer: systematic review of literature and meta-analysis OM Vanderveken, P Szturz, P Specenier, MC Merlano, M Benasso, ... The oncologist 21 (1), 59-71, 2016 | 25 | 2016 |
| Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2 C Bouchart, AL Trépant, M Hein, D Van Gestel, P Demetter Cancer Medicine 9 (3), 1069-1078, 2020 | 24 | 2020 |
| Clinical outcome and toxicity after simultaneous integrated boost IMRT in head and neck squamous cell cancer patients T Dragan, S Beauvois, M Moreau, M Paesmans, C Vandekerkhove, ... Oral oncology 98, 132-140, 2019 | 24 | 2019 |
Vincent GREGOIRECentre Léon Bérard在 lyon.unicancer.fr 的电子邮件经过验证
